Platelet-endothelial cell adhesion molecule-1 (CD31) expression on donor endothelial cells attenuates the development of transplant arteriosclerosis

Transplantation

Volumn 74, Issue 9, 2002, Pages 1267-1273

  Ensminger, Stephan M ^a,c   Spriewald, Bernd M ^a,c   Steger, Ulrich ^a   Morris, Peter J ^a   Mak, Tak W ^b   Wood, Kathryn J ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b AMGEN INSTITUTE   (Canada)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CYTOKINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; AORTA GRAFT; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENDOTHELIUM CELL; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LEUKOCYTE MIGRATION; MACROPHAGE; MORPHOMETRICS; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037112734     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200211150-00012     Document Type: Article

References (37)

1. Newman PJ, Berndt MC, Gorski J, et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247(4947): 1219.
2. Sun QH, DeLisser HM, Zukowski MM, Paddock C, Albelda SM, Newman PJ. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J Biol Chem 1996; 271(19): 11090.
3. Sun J, Williams J, Yan HC, Amin KM, Albelda SM, DeLisser HM. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem 1996; 271(31): 18561.
4. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today 1994; 15(10): 490.
5. Newman PJ. Switched at birth: A new family for PECAM-1. J Clin Invest 1999; 103(1): 5.
6. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction. J Immunol 1999; 163(2): 682.
7. Newman PJ. The biology of PECAM-1. J Clin Invest 1997; 100(11 suppl): S25.
8. Pober JS, Orosz CG, Rose ML, Savage CO. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61(3): 343.
9. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993; 178(2): 449.
10. Vaporciyan AA, DeLisser HM, Yan HC, et al. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 1993; 262(5139): 1580.
11. Bogen S, Pak J, Garifallou M, Deng X, Muller WA. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J Exp Med 1994; 179(3): 1059.
12. Gumina RJ, el Schultz J, Yao Z, et al. Antibody to platelet/endothelial cell adhesion molecule-1 reduces myocardial infarct size in a rat model of ischemia-reperfusion injury. Circulation 1996; 94(12): 3327.
13. Murohara T, Delyani JA, Albelda SM, Lefer AM. Blockade of platelet endothelial cell adhesion molecule-1 protects against myocardial ischemia and reperfusion injury in cats. J Immunol 1996; 156(9): 3550.
14. Plissonnier D, Nochy D, Poncet P, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995; 60(5): 414.
15. Hasegawa S, Becker G, Nagano H, Libby P, Mitchell RN. Pattern of graft-and host-specific MHC class II expression in long-term murine cardiac allografts: Origin of inflammatory and vascular wall cells. Am J Pathol 1998; 153(1): 69.
16. Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001; 107(11): 1411.
17. Duncan GS, Andrew DP, Takimoto H, et al. Genetic evidence for functional redundancy of platelet/endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999; 162(5): 3022.
18. Koulack J, McAlister VC, Giacomantonio CA, Bitter-Suermann H, MacDonald AS, Lee TD. Development of a mouse aortic transplant model of chronic rejection. Microsurgery 1995; 16(2): 110.
19. Ensminger SM, Spriewald BM, Sorensen HV, et al. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation. J Immunol 2001; 167(1): 532.
20. Spriewald BM, Hara M, Bushell A, Jenkins S, Morris PJ, Wood KJ. Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allografts. Am J Pathol 2000; 157(5): 1453.
21. Reiner S, Zheng S, Corry DB, Locksley RM. Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Methods 1993; 165(1): 37.
22. Ensminger SM, Spriewald BM, Witzke O, et al. Kinetics of transplant arteriosclerosis in MHC-class I and fully allogeneic aortic allografts. Transplantation 2002; 73(7): 1068.
23. Tilney N. Chronic rejection and its risk factors. Transplant Proc 1999; 13(1): 41S.
24. Langrehr JM, Hoffman RA, Lancaster JRJ, Simmons RL. Nitric oxide: A new endogenous immunomodulator. Transplantation 1993; 55(6): 1205.
25. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989; 83(5): 1774.
26. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996; 78(2): 225.
27. Noble K, Wickremasinghe RN, DeCornet C, Panayiotidis P, Young LY. Monocytes stimulate expression of the BcL-2 family member, A1, in endothelial cells and confer protection from apoptosis. J Immunol 1999; 162(3): 1376.
28. Evans PC, Taylor ER, Kilshaw PJ. Signaling through CD31 protects endothelial cells from apoptosis. Transplantation 2001; 71(3): 871.
29. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85(3): 221.
30. Gao Z, McAlister VC, Williams GM. Repopulation of liver endothelium by bone-marrow-derived cells. Lancet 2001; 357(9260): 923.
31. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107(11): 1395.
32. Quanini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346(1): 5.
33. Newman DK, Hamilton C, Newman PJ. Inhibition of antigen-receptor signaling by platelet endothelial cell adhesion molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 2001; 97(8): 2351.
34. Medawar PB. Transplantation of tissues and organs: Introduction. Br Med Bull 1965; 21: 97.
35. Sinclair RA. Origin of endothelium in human renal allografts. BMJ 1972; 4: 15.
36. Williams GM, Haar A, Parks LC, Krajewwski CA. Endothelial changes associated with hyperacute, acute and chronic renal allograft rejection in man. Transplant Proc 1973; 5: 819.
37. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2000; 357: 33.